FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2993145549> ?p ?o ?g. }

• W2993145549 endingPage "1101" @default.
• W2993145549 startingPage "1092" @default.
• W2993145549 abstract "People with chronic kidney disease (CKD) are at risk for adverse events and/or CKD progression with use of renally eliminated or nephrotoxic medications. To examine the prevalence of potentially inappropriate medication (PIM) use by U.S. adults by CKD stage and self-reported CKD awareness. Cross-sectional analysis of National Health and Nutrition Examination Surveys, 2011–2016 Non-pregnant adults with stages 3a (eGFR 45–59 mL/min/1.73 m2), 3b (eGFR 30–44), or 4–5 (eGFR < 30) CKD, stratified as CKD-aware/unaware. PIMs were identified on the basis of KDIGO guidelines, label information, and literature review. We calculated proportions using any and individual PIMs, assessing for differences over CKD awareness within each CKD stage. Analyses were adjusted for age, sex, race/ethnicity, education, comorbidities, and insurance type. Adjusted proportions of U.S. adults taking any PIM(s) exceeded 50% for all CKD stages and awareness categories, and were highest among CKD-unaware patients with stages 4–5 CKD: 66.6% (95% CI, 55.5–77.8). Proton pump inhibitors, opioids, metformin, sulfonylureas, and non-steroidal anti-inflammatory drugs (NSAIDs) were all used frequently across CKD stages. NSAIDs were used less frequently when CKD-aware by patients with stage 3a CKD (2.2% [95% CI, − 0.3 to 4.7] vs. 10.7% [95% CI, 7.6 to 13.8]) and stages 4–5 CKD (0.8% [95% CI, − 0.9 to 2.5] vs. 16.5% [95% CI, 4.0 to 29.0]). Metformin was used less frequently when CKD-aware by patients with stage 3b CKD (8.1% [95% CI, 0.3–15.9] vs. 26.5% [95% CI, 17.4–35.7]) and stages 4–5 CKD (none vs. 20.8% [95% CI, 1.8–39.8]). The impact of CKD awareness was statistically significant after correction for multiple comparisons only for NSAIDs in stage 3a CKD. PIMs are frequently used by people with CKD, with some impact of CKD awareness on NSAID and metformin use. This may lead to adverse outcomes or hasten CKD progression, reinforcing the need for improved medication management among people with CKD." @default.
• W2993145549 created "2019-12-13" @default.
• W2993145549 creator A5001881870 @default.
• W2993145549 creator A5005345204 @default.
• W2993145549 creator A5010011029 @default.
• W2993145549 creator A5021284558 @default.
• W2993145549 creator A5040329994 @default.
• W2993145549 creator A5041424888 @default.
• W2993145549 creator A5043773643 @default.
• W2993145549 creator A5057094852 @default.
• W2993145549 creator A5086057408 @default.
• W2993145549 date "2019-12-02" @default.
• W2993145549 modified "2023-10-16" @default.
• W2993145549 title "Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011–2016" @default.
• W2993145549 cites W1026936696 @default.
• W2993145549 cites W1986571696 @default.
• W2993145549 cites W1987528035 @default.
• W2993145549 cites W1987952223 @default.
• W2993145549 cites W1995528550 @default.
• W2993145549 cites W2000384121 @default.
• W2993145549 cites W2002885875 @default.
• W2993145549 cites W2034728281 @default.
• W2993145549 cites W2040626600 @default.
• W2993145549 cites W2057917288 @default.
• W2993145549 cites W2064555251 @default.
• W2993145549 cites W2108519035 @default.
• W2993145549 cites W2109202199 @default.
• W2993145549 cites W2111346120 @default.
• W2993145549 cites W2114293661 @default.
• W2993145549 cites W2135450314 @default.
• W2993145549 cites W2155965977 @default.
• W2993145549 cites W2172231857 @default.
• W2993145549 cites W2186709288 @default.
• W2993145549 cites W2227754270 @default.
• W2993145549 cites W2293040502 @default.
• W2993145549 cites W2335909636 @default.
• W2993145549 cites W2467227824 @default.
• W2993145549 cites W2505806553 @default.
• W2993145549 cites W2512638651 @default.
• W2993145549 cites W2591563250 @default.
• W2993145549 cites W2621228690 @default.
• W2993145549 cites W2749568779 @default.
• W2993145549 cites W2768325747 @default.
• W2993145549 cites W2802643432 @default.
• W2993145549 cites W2809031508 @default.
• W2993145549 cites W2809176080 @default.
• W2993145549 cites W2896965902 @default.
• W2993145549 cites W2897257410 @default.
• W2993145549 cites W2919576556 @default.
• W2993145549 cites W2922163122 @default.
• W2993145549 cites W4212810717 @default.
• W2993145549 doi "https://doi.org/10.1007/s11606-019-05557-8" @default.
• W2993145549 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7174522" @default.
• W2993145549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31792867" @default.
• W2993145549 hasPublicationYear "2019" @default.
• W2993145549 type Work @default.
• W2993145549 sameAs 2993145549 @default.
• W2993145549 citedByCount "6" @default.
• W2993145549 countsByYear W29931455492020 @default.
• W2993145549 countsByYear W29931455492021 @default.
• W2993145549 countsByYear W29931455492022 @default.
• W2993145549 crossrefType "journal-article" @default.
• W2993145549 hasAuthorship W2993145549A5001881870 @default.
• W2993145549 hasAuthorship W2993145549A5005345204 @default.
• W2993145549 hasAuthorship W2993145549A5010011029 @default.
• W2993145549 hasAuthorship W2993145549A5021284558 @default.
• W2993145549 hasAuthorship W2993145549A5040329994 @default.
• W2993145549 hasAuthorship W2993145549A5041424888 @default.
• W2993145549 hasAuthorship W2993145549A5043773643 @default.
• W2993145549 hasAuthorship W2993145549A5057094852 @default.
• W2993145549 hasAuthorship W2993145549A5086057408 @default.
• W2993145549 hasBestOaLocation W29931455491 @default.
• W2993145549 hasConcept C126189478 @default.
• W2993145549 hasConcept C126322002 @default.
• W2993145549 hasConcept C2778653478 @default.
• W2993145549 hasConcept C2779874844 @default.
• W2993145549 hasConcept C2780091579 @default.
• W2993145549 hasConcept C2908647359 @default.
• W2993145549 hasConcept C71924100 @default.
• W2993145549 hasConcept C74909509 @default.
• W2993145549 hasConcept C99454951 @default.
• W2993145549 hasConceptScore W2993145549C126189478 @default.
• W2993145549 hasConceptScore W2993145549C126322002 @default.
• W2993145549 hasConceptScore W2993145549C2778653478 @default.
• W2993145549 hasConceptScore W2993145549C2779874844 @default.
• W2993145549 hasConceptScore W2993145549C2780091579 @default.
• W2993145549 hasConceptScore W2993145549C2908647359 @default.
• W2993145549 hasConceptScore W2993145549C71924100 @default.
• W2993145549 hasConceptScore W2993145549C74909509 @default.
• W2993145549 hasConceptScore W2993145549C99454951 @default.
• W2993145549 hasFunder F4320337337 @default.
• W2993145549 hasFunder F4320337357 @default.
• W2993145549 hasIssue "4" @default.
• W2993145549 hasLocation W29931455491 @default.
• W2993145549 hasLocation W29931455492 @default.
• W2993145549 hasOpenAccess W2993145549 @default.
• W2993145549 hasPrimaryLocation W29931455491 @default.
• W2993145549 hasRelatedWork W1950083773 @default.

• next